Global Insight Services have recently published a report on Systemic Lupus Erythematosus Pipeline landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Systemic lupus erythematosus (SLE) also referred as lupus. It is a chronic, inflammatory autoimmune disease with multiorgan involvement. In this condition, the body attacks its own immune system and causes inflammation as well as tissue damage.
SLE is mainly of three types: 1) Acute cutaneous lupus erythematosus, 2) Chronic cutaneous or discoid lupus erythematosus and 3) Subacute cutaneous lupus erythematosus.
The exact cause of SLE condition is still unknown. Main factors associated with disease development and activity are environmental triggers, genetic predisposition and hormonal milieu interplay.
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31103
Report Highlights
Global Insight Service’s, Systemic Lupus Erythematosus – Drug Pipeline Landscape, 2022 report provides an overview of the Systemic Lupus Erythematosus pipeline drugs. This report covers detailed insights on Systemic Lupus Erythematosus drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Systemic Lupus Erythematosus pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Ask For Customization : https://www.globalinsightservices.com/request-customization/GIS31103
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.
Report Segmentation
- Assessment by Stage of Development
- Assessment by Companies
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Molecule Type
- Assessment by Route of Administration
Some of the key players involved in development of Systemic Lupus Erythematosus therapeutics are :
Key Players
• AbbVie
• Abcentra LLC
• Accro BioScience (Suzhou) Co Ltd
• Alexion Pharmaceuticals
• Aluda Pharmaceuticals Inc
• Amgen Inc
• Ampio Pharmaceuticals Inc
• ANNEXON INC
• Apellis Pharmaceuticals, Inc
• Aria Pharmaceuticals Inc
• Asahi Kasei Pharma Corporation
• AstraZeneca
• Athos Therapeutics
• Aurinia Pharmaceuticals Inc
• Avotres Inc
• BeiGene
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31103
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/